Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Resveratrol in Patients With Rheumatoid Arthritis.

NCT07089381 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07089381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07089381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Resveratrol in Patients With Rheumatoid Arthritis.
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Recruiting
Start date
August 1, 2025
Completion date
June 1, 2026
Enrollment
118 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anti aging, anti oxidative stress, antioxidant, c reactive protein, inflamation, methotrexate, quality of life outcomes, rheumatic arthritis, rheumatoid arthritis (ra) prevention